Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
REPROS THERAPEUTICS INC. (RPRX)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-17 | Jun-30-17 | Mar-31-17 | Dec-31-16 | Sep-30-16 | Jun-30-16 | Mar-31-16 | Dec-31-15 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Net income | -1.6 | -2.2 | -5.9 | -4.0 | -4.2 | -4.3 | -4.8 | -6.3 |
| Depreciation and amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Stock-based compensation | 0.1 | 0.1 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.8 |
| Change in working capital [+] | -0.2 | -0.1 | 0.9 | 0.4 | 0.1 | 0.2 | -1.0 | 0.7 |
| Other current assets | 0.1 | 0.0 | -0.2 | 0.1 | 0.1 | 0.0 | -0.2 | 0.2 |
| Other | -0.3 | -0.1 | 1.1 | 0.4 | 0.0 | 0.2 | -0.8 | 0.4 |
| Other operating activities | -0.3 | 0.2 | | | | 0.0 | | |
| Cash from operations | -2.0 | -2.0 | -4.6 | -3.1 | -3.6 | -3.5 | -5.3 | -4.8 |
| |
| Capital expenditures | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash from investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Issuance of common stock, net | | -1.0 | 1.0 | 1.3 | | | | |
| Other cash from financing | | 3.5 | | | 1.6 | | | |
| Cash from financing | 0.0 | 2.5 | 1.0 | 1.3 | 1.6 | 0.0 | 0.0 | 0.0 |
| |
| Free cash flow | -2.0 | -2.0 | -4.6 | -3.1 | -3.6 | -3.5 | -5.3 | -4.8 |
| Per share (diluted) | $0.00 | $0.00 | $0.00 | ($0.13) | ($0.15) | $0.00 | ($0.22) | ($0.20) |
|